Trend of health services coverage (%) in Ethiopia, 2003–2007.

a<p>The number of tuberculosis cases diagnosed during the reporting period.</p>b<p>The proportion of tuberculosis patients who have completed their treatment and been cured.</p>c<p>Expanded program of immunization: defined as receiving three doses of the combined vaccine against diphtheria, pertussis, and tetanus.</p>d<p>The proportion of reproductive-age women (15–49 years) who are accepting a modern contraceptive method (new and repeat acceptors).</p>e<p>The proportion of pregnant women who attended antenatal care at least once during their current pregnancy, and were seen by a health professional, for reasons related to their pregnancy.</p><p>Source: <a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000056#pmed.1000056-Ethiopian9" target="_blank">[21]</a>.</p

Decentralization of ART and chronic HIV care in Ethiopia, October 2006 and October 2007.

<p>Source: Monthly ART reports, National HIV/AIDS Prevention and Control Office, Ethiopian Ministry of Health.</p

Survey interview completion and the results of laboratory HIV testing among youth, 15–24 years old, Ethiopia -based HIV impact assessment 2017–2018.

(a) Frequencies and percent estimates are unweighted. (b) The EPHIA defines a non-defacto participant as a usual household member who did not sleep in the household the night before the survey.</p

Demographic characteristics, sexual risk behaviors, and health seeking behaviors of HIV-negative and unaware HIV-positive youth 15–24 years in urban Ethiopia, EPHIA 2017–2018.

Demographic characteristics, sexual risk behaviors, and health seeking behaviors of HIV-negative and unaware HIV-positive youth 15–24 years in urban Ethiopia, EPHIA 2017–2018.</p

Engagement in HIV testing among HIV-negative and unaware HIV-positive youth, 15–24 years old, Ethiopia population-based HIV impact assessment 2017–2018.

Flowchart of youth engagement in HIV testing prior to EPHIA survey participation among HIV-negative and unaware HIV-positive youth, aged 15–24 years. (a) percent estimates are weighted using jackknife survey replicate weights. (b) awareness of HIV status was confirmed via participant self-report of HIV status and HIV antiretroviral metabolite testing.</p

Percentage^† and prevalence ratio of testing for HIV ≤12 months among HIV-negative and unaware HIV-positive youth (15–24 years), by demographic characteristics, EPHIA 2017–2018.

Percentage† and prevalence ratio of testing for HIV ≤12 months among HIV-negative and unaware HIV-positive youth (15–24 years), by demographic characteristics, EPHIA 2017–2018.</p

Among youth ages 15–24 (HIV-negative and unaware HIV-positive), multinomial regression of HIV testing by select demographic characteristics, EPHIA 2017–2018.

Among youth ages 15–24 (HIV-negative and unaware HIV-positive), multinomial regression of HIV testing by select demographic characteristics, EPHIA 2017–2018.</p

Monthly trends of proportions of co-detection among SARS-CoV-2 positive cases from January 01, 2021, to June 30, 2022, Ethiopia.

Monthly trends of proportions of co-detection among SARS-CoV-2 positive cases from January 01, 2021, to June 30, 2022, Ethiopia.</p

Multivariable analysis of factors associated with SARS-CoV-2 co-infection with other respiratory viruses among ILI/SARI cases visited sentinel sites from January 2021 to June 2022, Ethiopia.

Multivariable analysis of factors associated with SARS-CoV-2 co-infection with other respiratory viruses among ILI/SARI cases visited sentinel sites from January 2021 to June 2022, Ethiopia.</p

Distribution of SARS-CoV-2 co-detection and mono-infections across SARI/ILI sentinel sites from January 01, 2021, to June 30, 2022, Ethiopia.

Distribution of SARS-CoV-2 co-detection and mono-infections across SARI/ILI sentinel sites from January 01, 2021, to June 30, 2022, Ethiopia.</p